Timothy E. Guertin Is Appointed to Varex Board of Directors: Provides Strong Corporate Governance Experience

IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

Martell Diagnostic Laboratories Announces HERTEST: Groundbreaking Way to Detect Effectiveness of Breast Cancer RX Globally

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM Improves Productivity for Long Part Machining by Automating Multi-spindle Program Creation

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

September 3, 2020

Timothy E. Guertin has been appointed to the Varex Imaging Board of Directors. The news was announced today.

Timothy E. Guertin is a member of the Board of Directors at Teradyne Inc., a maker of automated test equipment and industrial robotics, and Chair of the Global Access to Cancer Care Foundation, which works to expand the availability of modern cancer care in developing countries. He is the former Chief Executive Officer of Varian Medical Systems, Inc., a cancer care technologies and solutions company, where during his more than 35-year tenure with the company he held a number of senior management positions, including Executive Vice President and Chief Operating Officer, as well as President of Varian’s Oncology business unit. In connection with this appointment, the Varex Board increased its size to eight directors.

“I am very pleased to have Tim join the Varex Board of Directors. He is a seasoned board member with strong corporate governance experience and a highly accomplished corporate executive with deep knowledge of X-ray imaging technologies. Tim’s experience in both the medical and industrial verticals and segments will be an asset to the company, and we welcome him to our Board of Directors,” said Ruediger Naumann-Etienne, Chairman of the Board of Directors of Varex Imaging Corporation.

Mr. Guertin served on the board of Varian Medical Systems from 2005 to 2020, and on the board of KCI Holdings, Inc., a wound care company, until it was purchased by 3M in 2019. He has served as Vice-Chair of the Silicon Valley Leadership Group and as Treasurer of the Board of Trustees of the Radiation Oncology Institute, a cancer research organization. He is a graduate of the University of California at Berkeley with a BS degree in Electrical Engineering and Computer Sciences.

spot_img

DON'T MISS

Related Articles